Proteinuria Management at 300 mg/dL

Initial Assessment and Conservative Management

• For patients with proteinuria at 300 mg/dL, the American College of Physicians recommends initiating conservative management with renin-angiotensin system blockade (ACE inhibitors or ARBs) and blood pressure control, reserving immunosuppressive therapy only if proteinuria persists above 1 g/day despite 3-6 months of optimized supportive care 1, 2
• The Kidney Disease: Improving Global Outcomes (KDIGO) guideline suggests obtaining quantitative confirmation using spot urine protein-to-creatinine ratio (UPCR) or 24-hour urine collection to confirm persistent proteinuria 2

Blood Pressure Control and Supportive Measures

• The American Heart Association recommends targeting blood pressure <130/80 mmHg using ACE inhibitors or ARBs as first-line agents, as these medications reduce proteinuria independent of their blood pressure-lowering effects 3, 1
• The KDIGO guideline emphasizes that renin-angiotensin system blockade is the cornerstone of proteinuria management at all levels, and recommends sodium restriction to <2 g/day to enhance the antiproteinuric effect of renin-angiotensin system blockade 4, 2

Monitoring and Escalation of Care

• The National Kidney Foundation recommends rechecking UPCR and serum creatinine every 3-6 months to assess response to conservative therapy and detect progression 1, 2
• The KDIGO guideline suggests that the threshold for considering more aggressive intervention or nephrology referral occurs when proteinuria increases to >1 g/day (UPCR ≥1000 mg/g) despite 3-6 months of optimized conservative therapy 3, 1, 2

Critical Pitfalls to Avoid

• The American College of Physicians recommends not initiating immunosuppressive therapy at this level of proteinuria, as the risks outweigh benefits and spontaneous improvement is common with conservative management alone 5, 6, 1
• The KDIGO guideline suggests not assuming all proteinuria requires kidney biopsy - at 0.3 g/day without other concerning features, biopsy is not indicated 2

Prognosis and Treatment Goals

• The KDIGO guideline recommends that the treatment goal is to reduce proteinuria to <0.5 g/day and maintain stable kidney function 4, 1